Advertisement
SBFM vs SXTC
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SBFM is a StrongBuy and SXTC is a Buy.
SBFM in -3.64% downward trend, falling for three consecutive days on November 04, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where SBFM declined for three days, in 359 of 396 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Aroon Indicator for SBFM entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 20 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Moving Average Convergence Divergence (MACD) for SBFM just turned positive on October 23, 2026. Looking at past instances where SBFM's MACD turned positive, the stock continued to rise in 37 of 43 cases over the following month. The odds of a continued upward trend are 86%.
Following a +12.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where SBFM advanced for three days, in 117 of 166 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
SBFM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.382) is normal, around the industry mean (7.271). P/E Ratio (-0.296) is within average values for comparable stocks, (0.479). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.061) among similar stocks. P/S Ratio (0.070) is also within normal values, averaging (181.047).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 98 (best 1 - 100 worst), indicating slightly worse than average price growth. SBFM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SBFM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
Momentum Indicator for SXTC turns negative, indicating new downward trend
SXTC saw its Momentum Indicator move below the 0 level on October 08, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 110 similar instances where the indicator turned negative. In 105 of the 110 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SXTC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for SXTC entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +7.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where SXTC advanced for three days, in 155 of 180 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
SXTC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 46 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 51 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.185) is normal, around the industry mean (7.271). P/E Ratio (-0.050) is within average values for comparable stocks, (0.479). Projected Growth (PEG Ratio) (1.160) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.061) among similar stocks. P/S Ratio (0.016) is also within normal values, averaging (181.047).
The Tickeron PE Growth Rating for this company is 67 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 99 (best 1 - 100 worst), indicating slightly worse than average price growth. SXTC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SXTC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
SBFM | SXTC | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 29 Undervalued | 51 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 96 | 96 | |
PRICE GROWTH RATING 1..100 | 98 | 99 | |
P/E GROWTH RATING 1..100 | 98 | 67 | |
SEASONALITY SCORE 1..100 | 50 | 46 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SBFM's Valuation (29) in the null industry is in the same range as SXTC (51) in the Pharmaceuticals Major industry. This means that SBFM’s stock grew similarly to SXTC’s over the last 12 months.
SBFM's Profit vs Risk Rating (100) in the null industry is in the same range as SXTC (100) in the Pharmaceuticals Major industry. This means that SBFM’s stock grew similarly to SXTC’s over the last 12 months.
SBFM's SMR Rating (96) in the null industry is in the same range as SXTC (96) in the Pharmaceuticals Major industry. This means that SBFM’s stock grew similarly to SXTC’s over the last 12 months.
SBFM's Price Growth Rating (98) in the null industry is in the same range as SXTC (99) in the Pharmaceuticals Major industry. This means that SBFM’s stock grew similarly to SXTC’s over the last 12 months.
SXTC's P/E Growth Rating (67) in the Pharmaceuticals Major industry is in the same range as SBFM (98) in the null industry. This means that SXTC’s stock grew similarly to SBFM’s over the last 12 months.
| SBFM | SXTC | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 84% | N/A |
| Stochastic ODDS (%) | N/A | 5 days ago 90% |
| Momentum ODDS (%) | N/A | 4 days ago 90% |
| MACD ODDS (%) | 4 days ago 86% | N/A |
| TrendWeek ODDS (%) | 4 days ago 90% | 4 days ago 90% |
| TrendMonth ODDS (%) | 4 days ago 90% | 4 days ago 90% |
| Advances ODDS (%) | 12 days ago 70% | 6 days ago 86% |
| Declines ODDS (%) | 6 days ago 90% | 4 days ago 90% |
| BollingerBands ODDS (%) | 6 days ago 87% | 4 days ago 90% |
| Aroon ODDS (%) | 4 days ago 90% | 4 days ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
SBFM’s FA Score shows that 1 FA rating(s) are green while SXTC’s FA Score has 0 green FA rating(s).
- SBFM’s FA Score: 1 green, 4 red.
- SXTC’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
SBFM’s TA Score shows that 4 TA indicator(s) are bullish while SXTC’s TA Score has 3 bullish TA indicator(s).
- SBFM’s TA Score: 4 bullish, 2 bearish.
- SXTC’s TA Score: 3 bullish, 3 bearish.
Price Growth
SBFM (@Pharmaceuticals: Generic) experienced а -7.51% price change this week, while SXTC (@Pharmaceuticals: Generic) price change was -12.92% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.04%. For the same industry, the average monthly price growth was -9.05%, and the average quarterly price growth was +4.62%.
Reported Earning Dates
SBFM is expected to report earnings on Nov 12, 2026.
Industries' Descriptions
@Pharmaceuticals: Generic (-1.04% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
Advertisement
SBFM and
Correlation & Price change
A.I.dvisor tells us that SBFM and SXTC have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SBFM and SXTC's prices will move in lockstep.
| Ticker / NAME | Correlation To SBFM | 1D Price Change % | ||
|---|---|---|---|---|
| SBFM | 100% | -2.87% | ||
| SXTC - SBFM | 31% Poorly correlated | -3.41% | ||
| OGI - SBFM | 28% Poorly correlated | -5.72% | ||
| CGC - SBFM | 24% Poorly correlated | -3.58% | ||
| TLRY - SBFM | 24% Poorly correlated | +3.91% | ||
| ELAN - SBFM | 23% Poorly correlated | +8.70% | ||
More | ||||